Levy Raphi to sell 20,000 Alpha Tau shares (DRTS) via Form 144

Rhea-AI Filing Summary

Levy Raphi submitted a Form 144 notice to sell 20,000 Ordinary Shares of Alpha Tau Medical Ltd. acquired upon exercise of employee stock options, scheduled 07/01/2026 with cash payment upon exercise. The filing lists prior dispositions in June 2026: 17,500 shares on 06/23/2026, 20,000 shares on 06/25/2026, and 20,000 shares on 06/30/2026, each shown with gross proceeds in local currency.

Insights

Securities Counsel

Form 144 notice of proposed affiliate sale; timing and source are explicit.

The filing documents a proposed sale of 20,000 Ordinary Shares acquired upon exercise of employee stock options, with the method shown as cash payment upon exercise. The notice also lists three recent June 2026 dispositions by the same holder, with per‑trade share counts and gross proceeds.

Regulatory consequence: the notice is procedural — subsequent trades must comply with resale restrictions and Rule 144 conditions; further filings may show whether the sales were effected.

Equity Capital Markets Analyst

Insider/affiliate selling activity is documented; amounts are modest in isolation.

The record shows incremental sales in late June 2026 totaling 57,500 shares across three transactions and a planned sale of 20,000 shares on 07/01/2026. Each sale lists gross proceeds figures alongside share counts.

Practical point: these entries describe the holder's reported dispositions and planned resale; market impact depends on trading size versus public float, not disclosed here.

Key Figures

Proposed sale: 20,000 shares June 23, 2026 disposition: 17,500 shares June 25, 2026 disposition: 20,000 shares +3 more

6 metrics

Proposed sale 20,000 shares to be sold on 07/01/2026, acquired upon exercise of employee stock options

June 23, 2026 disposition 17,500 shares sold on 06/23/2026 with gross proceeds 167,051

June 25, 2026 disposition 20,000 shares sold on 06/25/2026 with gross proceeds 220,004

June 30, 2026 disposition 20,000 shares sold on 06/30/2026 with gross proceeds 240,044

Total June disposals (sum of listed trades) 57,500 shares aggregate of three June 2026 transactions shown in the excerpt

Broker‑dealer named Oppenheimer & Co. Inc. listed in securities information section (85 Broad St., New York)

Key Terms

Form 144, Ordinary Shares, acquired upon exercise of employee stock options, broker‑dealer

4 terms

Form 144 regulatory

"Form 144 notice to sell Ordinary Shares (first line of excerpt)"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Ordinary Shares financial

"Securities Information lists Ordinary Shares and Nasdaq (07/01/2026)"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

acquired upon exercise of employee stock options financial

"Shares acquired upon exercise of employee stock options (07/01/2026)"

broker‑dealer regulatory

"Oppenheimer & Co. Inc. 85 Broad St. New York (securities information)"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/02/2026 - 06:32 AM Accepted by SEC EDGAR 07/02/2026 - 06:32 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	20000	251600.00	88009737	07/01/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	07/01/2026	Shares acquired upon exercise of employee stock options	Alpha Tau Medical Ltd.			20000	07/01/2026	Cash payment upon exercise of stock options

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Levy Raphi KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	06/23/2026	17500	167051.00
Levy Raphi KIRYAT HAMADA 5, JERUSALEM L3 9777605	Ordinary Shares	06/25/2026	20000	220004.00
Levy Raphi KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary Shares	06/30/2026	20000	240044.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for DRTS / Alpha Tau Medical indicate?

The notice reports a proposed sale of 20,000 Ordinary Shares to occur on 07/01/2026, acquired upon exercise of employee stock options. It also lists prior June 2026 dispositions with share counts and gross proceeds.

Who is listed as the selling holder in the Form 144 for DRTS?

The filing identifies Levy Raphi (address details shown) as the holder reporting the proposed sale of 20,000 Ordinary Shares and prior June 2026 dispositions in the excerpt provided.

How many shares were sold in June 2026 according to the filing?

The excerpt lists three June 2026 dispositions totaling 57,500 shares: 17,500 on 06/23/2026, 20,000 on 06/25/2026, and 20,000 on 06/30/2026, each with gross proceeds shown.

What consideration is stated for the 07/01/2026 shares in the Form 144?

The filing states the 20,000 shares to be sold on 07/01/2026 were acquired upon exercise of employee stock options with cash payment upon exercise listed as the source of consideration.

Does the Form 144 excerpt show who handled the sale transactions?

Yes; Oppenheimer & Co. Inc. at 85 Broad St., New York is named in the securities information section, suggesting a broker‑dealer was involved in the transaction reporting.